Details for New Drug Application (NDA): 009900
✉ Email this page to a colleague
NDA 009900 describes CORTEF, which is a drug marketed by Pharmacia And Upjohn and is included in five NDAs. It is available from three suppliers. Additional details are available on the CORTEF profile page.
The generic ingredient in CORTEF is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
The generic ingredient in CORTEF is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
Summary for 009900
| Tradename: | CORTEF |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | hydrocortisone cypionate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | EQ 10MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
